Decreased reelin expression in the left prefrontal cortex (BA9) in chronic schizophrenia patients

Neuropsychobiology

Volumn 66, Issue 1, 2012, Pages 57-62

  Habl, Gregor ^a,b   Schmitt, Andrea ^c,g   Zink, Mathias ^a   Von Wilmsdorff, Martina ^d   Yeganeh Doost, Peyman ^c   Jatzko, Alexander ^e   Schneider Axmann, Thomas ^c   Bauer, Manfred ^f   Falkai, Peter ^c  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f UNIVERSITY OF LEIPZIG   (Germany)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Gene expression; In situ hybridization; Prefrontal cortex; Reelin; Schizophrenia

Indexed keywords

MESSENGER RNA; REELIN;

ARTICLE; CONTROLLED STUDY; ENTORHINAL CORTEX; GENE EXPRESSION; GRAY MATTER; HEMISPHERE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSORY CORTEX; TEMPORAL CORTEX; THALAMUS; THALAMUS DORSOMEDIAL NUCLEUS; WHITE MATTER;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES, NEURONAL; CELL MOVEMENT; CEREBRAL CORTEX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIPPOCAMPUS; HUMANS; IN SITU HYBRIDIZATION; MALE; MEDIODORSAL THALAMIC NUCLEUS; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; NEURONS; PREFRONTAL CORTEX; RNA, MESSENGER; SCHIZOPHRENIA; SERINE ENDOPEPTIDASES; SYNAPSES; THALAMUS;

EID: 84863890578     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000337129     Document Type: Article

References (28)

1. Weinberger DR: On the plausibility of 'the neurodevelopmental hypothesis' of schizophrenia. Neuropsychopharmacology 1996; 14: 1-11.
2. Shifman S, Johannesson M, Bronstein M, Chen SX, Collier DA, Craddock NJ, Kendler KS, Li T, O'Donovan M, O'Neill FA, Owen MJ, Walsh D, Weinberger DR, Sun C, Flint J, Darvasi A: Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet 2008; 4:e28.
3. Ben-David E, Shifman S, International Schizophrenia Consortium: Further investigation of the association between rs7341475 and rs17746501 and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2010; 153B:1244-1247.
4. Liu Y, Chen PL, McGrath J, Wolyniec P, Fallin D, Nestadt G, Liang KY, Pulver A, Valle D, Avramopoulos D: Replication of an association of a common variant in the Reelin gene (RELN) with schizophrenia in Ashkenazi Jewish women. Psychiatr Genet 2010; 20: 184-186.
5. Grayson DR, Jia X, Chen Y, Sharma RP, Mitchell CP, Guidotti A, Costa E: Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci USA 2005; 102: 9341-9346.
6. Abdolmaleky HM, Cheng KH, Russo A, Smith CL, Faraone SV, Wilcox M, Shafa R, Glatt SJ, Nguyen G, Ponte JF, Thiagalingam S, Tsuang MT: Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 2005; 134B:60-66.
7. Knuesel I: Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases. Prog Neurobiol 2010; 91: 257-274.
8. Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, Uzunov DP, Smalheiser NR, Davis JM, Pandey GN, Pappas GD, Tueting P, Sharma RP, Costa E: A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 1998; 95: 15718-15723.
9. Fatemi SH, Earle JA, McMenomy T: Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry 2000; 5: 654-563, 571.
10. Fatemi SH, Kroll JL, Stary JM: Altered levels of reelin and its isoforms in schizophrenia and mood disorders. Neuroreport 2001; 12: 3209-3215.
11. Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R, Uzunov D, Costa E: Decrease in reelin and glutamic acid decarboxylase 67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000; 57: 1061-1069
12. erratum in Arch Gen Psychiatry 2002; 59: 12.
13. Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB: Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry 2005 1; 57: 252-260.
14. Kim S, Webster MJ: The Stanley neuropathology consortium integrative database: a novel, web-based tool for exploring neuropathological markers in psychiatric disorders and the biological processes associated with abnormalities of those markers. Neuropsychopharmacology 2010; 35: 473-482.
15. Lipska BK, Mitkus SN, Mathew SV, Fatula R, Hyde TM, Weinberger DR, Kleinman JE: Functional genomics in postmortem human brain: abnormalities in a DISC1 molecular pathway in schizophrenia. Dialogues Clin Neurosci 2006; 8: 353-357.
16. Eastwood SL, Harrison PJ: Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis. Mol Psychiatry 2003; 8: 769, 821-831.
17. Eastwood SL, Harrison PJ: Cellular basis of reduced cortical reelin expression in schizophrenia. Am J Psychiatry 2006; 163: 540-542.
18. American PA: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
19. Jahn T, Mussgay L: Die statistische Kontrolle möglicher Medikamenteneinflüsse in experimentalpsychologischen Schizophreniestudien: ein Vorschlag zur Berechnung von Chlorpromazinäquivalenten. Z Klin Psychol 1989; 18: 257-267.
20. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-259.
21. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K: Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006; 112: 389-404.
22. Habl G, Zink M, Petroianu G, Bauer M, Schneider-Axmann T, von Wilmsdorff M, Falkai P, Henn FA, Schmitt A: Increased Damino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study. J Neural Transm 2009; 116: 1657-1665.
23. Dong E, Nelson M, Grayson DR, Costa E, Guidotti A: Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proc Natl Acad Sci USA 2008; 105: 13614-13619.
24. Costa E, Davis J, Grayson DR, Guidotti A, Pappas GD, Pesold C: Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol Dis 2001; 8: 723-742.
25. Jakob H, Beckmann H: Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 1986; 65: 303-326.
26. Falkai P, Schneider-Axmann T, Honer WG: Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality. Biol Psychiatry 2000; 47: 937-943.
27. Wedenoja J, Loukola A, Tuulio-Henriksson A, Paunio T, Ekelund J, Silander K, Varilo T, Heikkilä K, Suvisaari J, Partonen T, Lönnqvist J, Peltonen L: Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families. Mol Psychiatry 2008; 13: 673-684.
28. Wedenoja J, Tuulio-Henriksson A, Suvisaari J, Loukola A, Paunio T, Partonen T, Varilo T, Lönnqvist J, Peltonen L: Replication of association between working memory and Reelin, a potential modifier gene in schizophrenia. Biol Psychiatry 2010; 67: 983-991.